Treatment of Epilepsy with Myoclonic Absences in Children Younger Than 16

Epilepsy with myoclonic absences poses a particular management challenge in the pediatric population. When seizures persist despite pharmacological therapy, additional interventional strategies need to be considered in this age group.

Clinical scenario

Children (younger than 16 years) with epilepsy with myoclonic absences who have continued seizures despite appropriate antiepileptic drug therapy.

Management approach — partial overview

For medically refractory seizures in this age group, non-pharmacologic interventional approaches may be indicated when medications alone have not achieved seizure control. The specific options, criteria, and sequencing are detailed in the full protocol.

Instant Access to Structured Evidence-Based Regimens

References

Children (younger than 16 years)

These patients have continued seizures despite appropriate AED therapy.

For patients with seizures that are not controlled with these agents, alternative treatments include surgical resection of the seizure focus, ketogenic diets, vagus nerve stimulators, and implantable brain neurostimulators.

View source ↗